Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -257,000 | 294,317 | 414,000 | 410,000 | -289,000 |
| Other Operating Activity | 257,000 | -294,317 | -414,000 | -410,000 | 289,000 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -200,000 | -260,234 | -268,000 | -189,000 | -269,000 |
| Net Acquisitions | N/A | -232,964 | -12,000 | 124,000 | -729,000 |
| Purchase Of Investment | -7,000 | 441,200 | -330,000 | -39,000 | -119,000 |
| Sale Of Investment | 36,000 | -164,978 | 57,000 | 195,000 | 52,000 |
| Other Investing Activity | 0 | -1,314,177 | 12,000 | -124,000 | 729,000 |
| Investing Cash Flow | $-171,000 | $-1,531,152 | $-541,000 | $-33,000 | $-336,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,000 | 27,528 | 27,000 | 45,000 | 45,000 |
| Common Stock Repurchased | -504,000 | -1,278,028 | 0 | 0 | -457,000 |
| Dividend Paid | -545,000 | -553,347 | -547,000 | -1,067,000 | -163,000 |
| Other Financing Activity | 502,000 | -803,291 | 651,000 | 1,070,000 | 222,000 |
| Financing Cash Flow | $-529,000 | $-2,607,137 | $131,000 | $48,000 | $-353,000 |
| Exchange Rate Effect | -8,000 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | -2,101,000 | N/A | N/A | N/A | N/A |
| End Cash Position | -2,221,000 | 717,824 | -229,000 | -531,000 | -993,000 |
| Net Cash Flow | $-112,000 | $-384,213 | $302,000 | $462,000 | $-993,000 |
| Free Cash Flow | |||||
| Capital Expenditure | -208,000 | -359,686 | -287,000 | -220,000 | -251,000 |
| Free Cash Flow | -208,000 | -359,686 | -287,000 | -220,000 | -251,000 |